Nicolas Zhou

Sep 6, 2024 | digitalcommons.library.tmc.edu | Nathaniel Deboever |Nicolas Zhou |Daniel J. McGrail |Katarzyna Tomczak

BACKGROUND: Malignant pleural mesothelioma (MPM) is associated with poor prognosis despite advances in multimodal therapeutic strategies. While patients with resectable disease may benefit from added survival with oncologic resection, patient selection for mesothelioma operations often relies on both objective and subjective evaluation metrics.